The global Respiratory Drug Delivery market is expected to reach USD 523.7 Billion by 2021, from USD 36.1 Billion in 2016, at a CAGR of 6% during the forecast period. The market is growing due to factors such as a growing preference for the pulmonary route as an alternative route of drug delivery, a growing interest in developing smart/digital inhalers, and an increasing incidence of respiratory diseases such as COPD, asthma, and cystic fibrosis. .
A full report of Respiratory Drugs and Devices Market available at: https://www.orionmarketreports.com/respiratory-drugs-and-devices-market/10876/
Major Players
Key Companies in the global respiratory drugs and devices market include GE Healthcare, Philips Healthcare, Roche, Merck & Co., GlaxoSmithKline, Baxter International, and others.
Respiratory Drugs and Devices Market- Segmentation
By Formulations
Type
• Suspension Aerosol
• Solution Aerosol
• Dry Powder Formulation
Device Type
• Metered Dose Inhalers (MDI)
• Dry Powder Inhalers (DPI)
• Nebulizers
By Canister Type
• Plain Canister
• Coated Canister
By Applications
• Asthma
• COPD
• Cystic Fibrosis
By End User
• Hospitals &Clinics
• Homecare settings
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
